The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer
- PMID: 18409186
- DOI: 10.1002/pros.20759
The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer
Abstract
Background: To analyze to what extent the percentage of suspicious digital rectal examination (DRE) findings vary between examiners and to what extent the percentage of prostate cancers (PCs) detected in men with these suspicious findings varies between examiners.
Methods: In the first screening round of the European Randomized study of Screening for PC (ERSPC) Rotterdam, 7,280 men underwent a PSA-determination and DRE of whom 2,102 underwent prostate biopsy (biopsy indication PSA > or = 4.0 ng/ml and/or suspicious DRE and/or TRUS). Descriptive statistics of DRE-outcome per PSA-range were used to determine the observer variability of six examiners. Because this analysis did not correct properly for other predictors of a suspicious DRE (PSA-level, biopsy indication, TRUS-outcome, prostate volume and age), a logistic regression analysis controlling for these explanatory variables was performed as well.
Results: In 2,102 men biopsied, 443 PCs were detected (PPV = 21%). For all PSA levels the percentage suspicious DRE varied between examiners from 4% to 28% and percentage PC detected in men with a suspicious DRE varied from 18% to 36%. Logistic regression analysis showed that three of six examiners considered DRE significantly more often abnormal than others (ORs 3.48, 2.80, 2.47, P < 0.001). For all examiners the odds to have PC was statistically significantly higher in case of a suspicious DRE (ORs 2.21-5.96, P < 0.05). This increased chance to find PC was not significantly observer-dependent.
Conclusions: Three of six examiners considered DRE significantly more often suspicious than the others. However, under equal circumstances a suspicious DRE executed by each examiner increased the chance of the presence of PC similarly.
Similar articles
-
The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.Eur Urol. 2008 Sep;54(3):581-8. doi: 10.1016/j.eururo.2008.03.104. Epub 2008 Apr 8. Eur Urol. 2008. PMID: 18423977 Clinical Trial.
-
Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.Eur Urol. 2009 Jan;55(1):139-46. doi: 10.1016/j.eururo.2008.03.079. Epub 2008 Apr 1. Eur Urol. 2009. PMID: 18406045 Clinical Trial.
-
Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.Eur Urol. 2012 Mar;61(3):577-83. doi: 10.1016/j.eururo.2011.11.012. Epub 2011 Nov 15. Eur Urol. 2012. PMID: 22104592
-
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Oncol. 2024 Aug;7(4):697-704. doi: 10.1016/j.euo.2023.12.005. Epub 2024 Jan 4. Eur Urol Oncol. 2024. PMID: 38182488
-
Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.J Natl Med Assoc. 2006 Apr;98(4):492-504. J Natl Med Assoc. 2006. PMID: 16623061 Free PMC article. Review.
Cited by
-
To what extent are anorectal function tests comparable? A study comparing digital rectal examination, anal electromyography, 3-dimensional high-resolution anal manometry, and transperineal ultrasound.Int J Colorectal Dis. 2023 Jan 16;38(1):12. doi: 10.1007/s00384-022-04304-6. Int J Colorectal Dis. 2023. PMID: 36645523 Free PMC article.
-
Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?BJUI Compass. 2021 May 4;2(3):188-193. doi: 10.1002/bco2.69. eCollection 2021 May. BJUI Compass. 2021. PMID: 35475129 Free PMC article.
-
Neoadjuvant Therapy in High-Risk Prostate Cancer.Indian J Urol. 2020 Oct-Dec;36(4):251-261. doi: 10.4103/iju.IJU_115_20. Epub 2020 Oct 1. Indian J Urol. 2020. PMID: 33376260 Free PMC article. Review.
-
Age-specific PCA3 score reference values for diagnosis of prostate cancer.World J Urol. 2012 Jun;30(3):405-10. doi: 10.1007/s00345-011-0749-1. Epub 2011 Aug 30. World J Urol. 2012. PMID: 21877172
-
Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy.Ann Med. 2023;55(2):2279235. doi: 10.1080/07853890.2023.2279235. Epub 2023 Nov 8. Ann Med. 2023. PMID: 37939258 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous